Yescarta competitor: Kymriah has manufacturing problems | GILD Message Board Posts

Gilead Sciences, Inc.

  GILD website

GILD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  11835 of 11877  at  12/11/2018 8:16:45 AM  by

captsolo


 In response to msg 11834 by  mymorningsong
view thread

Re: Yescarta competitor: Kymriah has manufacturing problems

"Yet, about eight months on from securing a second approval for Kymriah (tisagenlecleucel), the company is still delivering the CAR-T treatment to some patients for free, unable to charge for a product that while OK for use in patients doesn't meet stricter specifications established for commercial use."


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 203
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...